Detalles de la búsqueda
1.
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Nat Immunol;
21(11): 1346-1358, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868929
2.
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells.
Immunity;
53(1): 187-203.e8, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640259
3.
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Nature;
600(7890): 727-730, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34912120
4.
Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
Cancer Sci;
115(5): 1622-1633, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429886
5.
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
Lancet;
402(10418): 2197-2208, 2023 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37871604
6.
[Chemotherapy for Unresectable Advanced, Metastatic or Recurrent Colorectal Cancer].
Gan To Kagaku Ryoho;
51(3): 245-249, 2024 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-38494801
7.
Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma.
Cancer Sci;
114(4): 1606-1615, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36478334
8.
HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
Gastroenterology;
162(3): 799-812, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34687740
9.
Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein-Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery.
Ann Surg Oncol;
30(8): 5227-5236, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36934377
10.
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience.
Gastric Cancer;
26(6): 1030-1039, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37665515
11.
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
Support Care Cancer;
30(5): 4497-4504, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113224
12.
Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors.
Int J Clin Oncol;
27(9): 1413-1420, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35713753
13.
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
Proc Natl Acad Sci U S A;
116(20): 9999-10008, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31028147
14.
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study.
Invest New Drugs;
39(6): 1649-1655, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019214
15.
A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604).
Gastric Cancer;
24(1): 190-196, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32700159
16.
Current status of immunotherapy for advanced gastric cancer.
Jpn J Clin Oncol;
51(1): 20-27, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33241322
17.
Short-term safety of adjuvant chemoradiotherapy after local resection for patients with high-risk submucosal invasive rectal cancer: a single-arm, multicenter phase II trial.
Jpn J Clin Oncol;
51(5): 707-712, 2021 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558891
18.
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.
Int J Clin Oncol;
26(11): 2017-2024, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34291369
19.
Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial.
Lancet Oncol;
21(8): 1057-1065, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32589866
20.
Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
BMC Cancer;
20(1): 1111, 2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198652